126 related articles for article (PubMed ID: 11858494)
1. Ticlopidine inhibits the prothrombotic effects of thrombopoietin and ameliorates survival after supralethal total body irradiation.
Mouthon MA; Gaugler MH; Vandamme M; Gourmelon P; Wagemaker G; Van der Meeren A
Thromb Haemost; 2002 Feb; 87(2):323-8. PubMed ID: 11858494
[TBL] [Abstract][Full Text] [Related]
2. Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.
Mouthon MA; Gaugler MH; Van der Meeren A; Vandamme M; Gourmelon P; Wagemaker G
Exp Hematol; 2001 Jan; 29(1):30-40. PubMed ID: 11164103
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin from human embryonic kidney cells causes increased thrombocytopoiesis in sublethally irradiated mice.
Carter CD; McDonald TP
Radiat Res; 1992 Oct; 132(1):74-81. PubMed ID: 1410278
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
5. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
6. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
Herbert JM; Bernat A; Samama M; Maffrand JP
Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
[TBL] [Abstract][Full Text] [Related]
7. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
8. Modification of gamma radiation induced response of peritoneal macrophages and splenocytes by Hippophae rhamnoides (RH-3) in mice.
Prakash H; Bala M; Ali A; Goel HC
J Pharm Pharmacol; 2005 Aug; 57(8):1065-72. PubMed ID: 16102264
[TBL] [Abstract][Full Text] [Related]
9. Preferential liver irradiation enhances hematopoiesis through a thrombopoietin-independent mechanism.
Mouthon MA; Vandamme M; Gourmelon P; Vainchenker W; Wendling F
Radiat Res; 1999 Oct; 152(4):390-7. PubMed ID: 10477915
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
Saitoh H; Matsumoto H; Takayama T; Ide H; Miyawaki F; Furuse A
Kokyu To Junkan; 1989 Jan; 37(1):87-92. PubMed ID: 2734499
[TBL] [Abstract][Full Text] [Related]
11. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
16. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
17. Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
Straub A; Krajewski S; Hohmann JD; Westein E; Jia F; Bassler N; Selan C; Kurz J; Wendel HP; Dezfouli S; Yuan Y; Nandurkar H; Jackson S; Hickey MJ; Peter K
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1607-16. PubMed ID: 21512161
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation.
Evangelista V; Manarini S; Dell'Elba G; Martelli N; Napoleone E; Di Santo A; Lorenzet PS
Thromb Haemost; 2005 Sep; 94(3):568-77. PubMed ID: 16268474
[TBL] [Abstract][Full Text] [Related]
20. P2Y receptor antagonists in thrombosis.
Boeynaems JM; van Giezen H; Savi P; Herbert JM
Curr Opin Investig Drugs; 2005 Mar; 6(3):275-82. PubMed ID: 15816504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
